Thermo Fisher Scientific Inc [TMO] stock is trading at $585.07, up 0.75%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The TMO shares have gain 3.04% over the last week, with a monthly amount drifted -1.38%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Thermo Fisher Scientific Inc [NYSE: TMO] stock has seen the most recent analyst activity on December 11, 2025, when Citigroup upgraded its rating to a Buy but kept the price target unchanged to $660 for it. Previously, Goldman started tracking the stock with Buy rating on December 09, 2025, and set its price target to $685. On December 08, 2025, upgrade upgraded it’s rating to Overweight but maintained its price target of $750 on the stock. HSBC Securities upgraded its rating to a Buy but $670 remained the price target by the analyst firm on December 01, 2025. Barclays upgraded its rating to Overweight for this stock on September 11, 2025, but kept the price target unchanged to $550. In a note dated August 19, 2025, William Blair initiated an Outperform rating.
Thermo Fisher Scientific Inc [TMO] stock has fluctuated between $385.46 and $610.97 over the past year. Currently, Wall Street analysts expect the stock to reach $630.7 within the next 12 months. Thermo Fisher Scientific Inc [NYSE: TMO] shares were valued at $585.07 at the most recent close of the market. An investor can expect a potential return of 7.8% based on the average TMO price forecast.
Analyzing the TMO fundamentals
Thermo Fisher Scientific Inc [NYSE:TMO] reported sales of 43.74B for the trailing twelve months, which represents a growth of 4.94%. Gross Profit Margin for this corporation currently stands at 0.4% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.16%, and Net Profit Margin reading is 0.15%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.13 and Total Capital is 0.09. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.7.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 581.69 points at the first support level, and at 578.32 for the second support level. However, for the 1st resistance point, the stock is sitting at 586.87, and for the 2nd resistance point, it is at 588.68.
Ratios To Look Out For
For context, Thermo Fisher Scientific Inc’s Current Ratio is 1.50. As well, the Quick Ratio is 1.11, while the Cash Ratio is 0.13. Considering the valuation of this stock, the price to sales ratio is 5.03, the price to book ratio is 4.31 and price to earnings (TTM) ratio is 33.81.
Transactions by insiders
Recent insider trading involved Lagarde Michel, Executive Vice President & COO, that happened on Dec 04 ’25 when 22046.0 shares were sold. Executive Vice President & COO, Lagarde Michel completed a deal on Dec 03 ’25 to sell 32000.0 shares. Meanwhile, Executive Vice President & COO Lagarde Michel sold 30000.0 shares on Dec 02 ’25.
